Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAM vs. Sequential High-Dose Therapy + BEAM in Relapsed Hodgkin's Lymphoma
NCT00025636Phase 3Unknown
- Sponsor
- German Hodgkin Study Group
- Start
- Jul 2001
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of cyclophosphamide, methotrexate, vincristine, etoposide in Hodgkin lymphoma (HL), sponsored by German Hodgkin Study Group. Status: unknown.
02
Drugs
cyclophosphamidemethotrexatevincristineetoposide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00025636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00025636.